Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block vs Usual Care for Mechanical Back Pain
NCT05982483Completed
- Sponsor
- Island Health
- Start
- Sep 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of bupivacaine in Mechanical Back Pain (2 cohorts), sponsored by Island Health. Primary endpoint: Numeric Verbal Pain Score reduction at emergency department discharge. Started Sep 2019; status: completed.
02
Drugs
bupivacaine
03
Conditions
Mechanical Back Pain
Beyond the preview
Go deeper on NCT05982483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05982483.